Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 11/2023

26.05.2023 | Image of the Month

Not all black colons on [18F]FDG PET are due to metformin

verfasst von: Lennert Boeckxstaens, Vibeke Vergote, Daan Dierickx, Thomas Tousseyn, Didier Bielen, Koen Van Laere, Christophe M. Deroose, Karolien Goffin

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Excerpt

Antidiabetic treatment with metformin is known to induce changes in glucose uptake in normal organs [1]. Metformin treatment increases [18F]FDG-uptake in the bowel with typically intense and diffuse uptake along the bowel, strongly predominant in the colon [2]. We here report a case with a similar pattern of intense and diffuse [18F]FDG-uptake along the colon of a 58-year-old patient experiencing rectal bleeding and diarrhea with a medical history of lung transplantation due to end-stage interstitial lung disease. Simultaneously acquired CT images of the [18F]FDG PET/CT demonstrate wall thickening of the entire colon with mild infiltration of the paracolic fat tissue and some prominent mesenterial lymph nodes. [18F]FDG PET/CT also demonstrates a liver lesion cranially in the liver and multiple lymph nodes with high [18F]FDG-uptake. Given the highly elevated EBV PCR titers (6758 IU/ml) the lesions were strongly suspicious of posttransplant lymphoproliferative disease (PTLD). A colonoscopy was performed to exclude PTLD in the colon and showed severe colitis with ulcerations of which anatomopathological analysis confirmed PTLD. Diffuse and intense [18F]FDG-uptake in the bowel is also observed in other cases of graft-versus-host disease and inflammatory bowel disease [3, 4]. Intense [18F]FDG-uptake in the bowel is not always induced by metformin treatment and further examination can be required, especially when gastrointestinal symptoms are present. …
Literatur
1.
Metadaten
Titel
Not all black colons on [18F]FDG PET are due to metformin
verfasst von
Lennert Boeckxstaens
Vibeke Vergote
Daan Dierickx
Thomas Tousseyn
Didier Bielen
Koen Van Laere
Christophe M. Deroose
Karolien Goffin
Publikationsdatum
26.05.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06269-2

Weitere Artikel der Ausgabe 11/2023

European Journal of Nuclear Medicine and Molecular Imaging 11/2023 Zur Ausgabe